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TRANSCRIPTOMICS
How to build a human
The genes that control the development of specific tissues and organs in
human embryos have been identified.
CARLA B MELLOUGH AND MAJLINDA LAKO
T
he manual for human development is
written in the genetic code of our DNA.
Our genes encode the instructions to
make specific types of molecules that are
needed to either build the human body or to
control its day-to-day operations. The first step
in producing these molecules involves the gene
being copied, or transcribed, into an RNA mole-
cule. For some genes, this RNA molecule is the
end product; for other genes, the RNA molecule
must then be translated to produce a protein.
Mistakes, or mutations, in a gene often
change the RNA or protein produced, and even
the smallest of changes can have far-reaching
effects. For example, if these mutations affect
molecules that are needed when a human
embryo is developing in the womb, they can
lead to severe abnormalities that are collectively
called congenital disorders. A cleft palate is a
relatively common example of a congenital dis-
order, and affects one in every 700 babies born
each year (Forrester and Merz, 2004;
Parker et al., 2010). Similarly, mutations that
result in genes being active at the wrong time,
or in the wrong cells in a developing embryo,
can also lead to congenital disorders. In addi-
tion, exposure to toxic or infectious agents can
also be a cause. This is exemplified by the drug
thalidomide, which was administered to preg-
nant women between 1956 and 1962, and has
caused severe birth defects in around 10,000
children worldwide (McBride, 1961).
Understanding why organs sometimes form
incorrectly is challenging, largely because tissue
from developing human embryos is rarely avail-
able for study. Instead, research has tended to
extrapolate information from multiple sources,
including individuals born with specific
disorders, animal models and cell-based labora-
tory models of development and disease
(Azamian and Lalani, 2016; Moretti et al.,
2013; Kelly, 2016).
Some studies have investigated which genes
are expressed in developing human embryos by
looking at the RNA molecules produced at a
given time. These “transcriptomics” studies,
however, have tended to look at the embryo as
a whole (Fang et al., 2010), or to focus on spe-
cific organs and tissues in more developed
embryos (van den Berg et al., 2015;
Slieker et al., 2015). Consequently, little was
known about the formation and early develop-
ment of organs – a process called organogenesis
– in humans.
Over the past year or so, data on this crucial
process has started to emerge. First, in mid-
2015, a study described the transcriptional pro-
files of human embryos from different develop-
mental stages (Roost et al., 2015). Now, in
eLife, Neil Hanley and co-workers – from the
University of Manchester and the Central Man-
chester University Hospitals NHS Foundation
Trust – report transcriptomics data obtained
during human organogenesis (Gerrard et al.,
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2016). The human embryonic material used in
the study was collected according to the Codes
of Practice of the UK Human Tissue Authority
(HTA, 2016).
Hanley and co-workers – who include Dave
Gerrard and Andrew Berry as joint first authors –
looked at the RNA molecules found in organs
and tissues from fifteen separate sites in human
embryos. These sites included the thyroid, liver,
stomach, brain, heart and adrenal gland. Ger-
rard et al. were then able to integrate this data
into a sort of atlas that mapped the activity level
of developmental genes across the embryo. This
in turn allowed them to identify eleven groups
of genes that were expressed differently in the
different organs and tissues examined. Gerrard
et al. refer to these groups of genes as meta-
genes and the activity levels of genes found in
each metagene form a kind of transcriptional
barcode for each of the different tissue types of
the body.
Many cell-based models of development use
stem cells from human embryos, or other cells
that have been reprogrammed to be more like
stem cells (so-called induced pluripotent stem
cells; Takahashi et al., 2007). However, these
approaches have their limitations (Hrvatin et al.,
2014; Patterson et al., 2012), and it is challeng-
ing to ensure that stem cells differentiate into
completely mature tissues in vitro. Gerrard et al.
confirmed that the transcriptional barcode asso-
ciated with the embryonic liver (metagene 2)
was also seen in liver tissue derived from stem
cells grown in the laboratory. This suggests that
the transcriptional barcodes could be used to
check that lab-grown stem cells have differenti-
ated and matured as intended. Moreover, know-
ing which genes actively direct the cells in
embryos to differentiate in specific ways could
help other researchers to coax stem cells to
become a wider range of tissues in vitro.
The work of Gerrard et al. adds substantially
to what is known about the transcriptional pro-
files of each of the organs and tissues in a devel-
oping human embryo, and about the disorders
associated with these tissues. Furthermore, their
findings complement what we know about the
later stages of embryonic development
(Roost et al., 2015), and will allow a greater
understanding of the distinct events that occur
during human development and disease.
The findings by Hanley, Gerrard, Berry and
colleagues have great implications for improving
stem cell research. They will also undoubtedly
aid research into diseases that develop at later
stages of development, which has proved
particularly challenging so far. Might we be on
the cusp of completing the last pages of the
‘how to build a human’ manual? If so, soon we
may finally be able to generate mature tissues
more routinely in vitro and unravel the unknown
mechanisms of development and disease.
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